Home / Stocks / NVMI

Nova (NVMI, Chipmaking equipment) Stock Valuation & Fair Value

Trading above its usual valuation

Nova (NVMI, Chipmaking equipment) trades at a current P/E of 29.9, about 30% above its historical normal valuation, with a forward growth estimate of 27.5% and a PEG of 1.09. Analysts' one-year estimates have been hit 18% of the time. Priced at its historical normal P/E of 23.1 on the same blended earnings, the 2026-11-06 close of $313.18 corresponds to about $242 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

DATA AS OF 2026-11-07
Current P/E
29.9
Normal P/E
23.1
PEG
1.09
Fwd growth
27.5%
Div yield
0.0%
RSI (14)
44.5
Neutral
Technical context
  • Price $313.18 at the Nov 6 close, 1.8% below the 20-day average ($318.88) and 9.6% below the 50-day ($346.38).
  • RSI (14) at 44.5.
  • 52-week range $275.78 to $605.65: the price is 48.3% below the high and 13.6% above the low.

The Street vs SeerForecast

Wall Street's mean price target for NVMI is $515.12 across 8 analysts, 64.5% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: trading above its usual valuation. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating changed 2 times after 2026-09-19 and is back where it started: poor on forward returns as of 2026-11-02.

Current P/E and rating by weekCurrent P/E moved from 35.2 to 30.2 between 2026-09-18 and 2026-10-30, against a normal P/E of 23.1, with 2 rating changes over 7 recorded weeks.2026-09-18: P/E 35.2, Significantly overvalued, recalculated for the week of 2026-09-192026-09-18: P/E 35.2, Significantly overvalued, recorded live 2026-09-212026-09-25: P/E 36.3, Significantly overvalued, recalculated for the week of 2026-09-262026-09-25: P/E 36.3, Significantly overvalued, recorded live 2026-09-282026-10-02: P/E 38.9, Significantly overvalued, recalculated for the week of 2026-10-032026-10-02: P/E 38.9, Significantly overvalued, recorded live 2026-10-052026-10-09: P/E 34.5, Significantly overvalued, recalculated for the week of 2026-10-102026-10-09: P/E 34.5, Significantly overvalued, recorded live 2026-10-122026-10-16: P/E 31.3, Trading above its usual valuation, recalculated for the week of 2026-10-172026-10-16: P/E 31.3, Trading above its usual valuation, recorded live 2026-10-192026-10-23: P/E 30.2, Trading above its usual valuation, recalculated for the week of 2026-10-242026-10-23: P/E 30.2, Trading above its usual valuation, recorded live 2026-10-262026-10-30: P/E 30.2, Poor on forward returns, recalculated for the week of 2026-10-312026-10-30: P/E 30.2, Poor on forward returns, recorded live 2026-11-0225.030.035.0Sep 18Sep 28Oct 9Oct 20Oct 30Normal P/E 23.1
Trading above its usual valuationSignificantly overvaluedPoor on forward returnsLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 35.2+53%Significantly overvalued (recalculated)
2026-10-03P/E 38.9+69%Significantly overvalued (recalculated)
2026-10-17P/E 31.3+36%Trading above its usual valuation (recalculated)
2026-10-31P/E 30.2+31%Poor on forward returns (recalculated) (across a rating rules change)
2026-11-02P/E 30.2+31%Poor on forward returns ← now
Show all 14 readings
WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 35.2+53%Significantly overvalued (recalculated)
2026-09-21P/E 35.2+53%Significantly overvalued
2026-09-26P/E 36.3+57%Significantly overvalued (recalculated)
2026-09-28P/E 36.3+57%Significantly overvalued
2026-10-03P/E 38.9+69%Significantly overvalued (recalculated)
2026-10-05P/E 38.9+69%Significantly overvalued
2026-10-10P/E 34.5+50%Significantly overvalued (recalculated)
2026-10-12P/E 34.5+50%Significantly overvalued
2026-10-17P/E 31.3+36%Trading above its usual valuation (recalculated)
2026-10-19P/E 31.3+36%Trading above its usual valuation
2026-10-24P/E 30.2+31%Trading above its usual valuation (recalculated)
2026-10-26P/E 30.2+31%Trading above its usual valuation
2026-10-31P/E 30.2+31%Poor on forward returns (recalculated) (across a rating rules change)
2026-11-02P/E 30.2+31%Poor on forward returns ← now

Frequently asked questions

Is Nova stock overvalued?

At a current P/E of 29.9 versus its historical normal P/E of 23.1, Nova trades about 30% above its typical valuation, with a PEG of 1.09 on 27.5% forward growth. tickerseer currently rates it trading above its usual valuation.

What is Nova's fair value and PEG?

Nova trades at a current P/E of 29.9 against a historical normal P/E of 23.1, a PEG of 1.09, and a forward growth estimate of 27.5%. Priced at its historical normal P/E of 23.1 on the same blended earnings, the 2026-11-06 close of $313.18 corresponds to about $242 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Nova changed?

tickerseer's rating changed 2 times after 2026-09-19 and is back where it started: poor on forward returns as of 2026-11-02.

What is the analyst price target for Nova?

The mean Wall Street price target for Nova is $515.12 across 8 analysts, 64.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Chipmaking equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track NVMI free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.